Blick S - Search Results

1

Differential effects of ergometer-cycling and Whole-Body-Vibration training on serological BDNF and IGF-1 in the treatment of adolescent depression - is there an impact of BDNFp.Val66Met variants?

Wunram HL, Oberste M, Ziemendorff A, Hamacher S, Kapanci T, Heller R, Blick S, Bloch W, Clajus TC, Schönau E, Bender S, Fricke O. Wunram HL, et al. Among authors: blick s. Physiol Behav. 2021 Nov 1;241:113596. doi: 10.1016/j.physbeh.2021.113596. Epub 2021 Sep 15. Physiol Behav. 2021. PMID: 34536433

2

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.

Wirth B, Brichta L, Schrank B, Lochmüller H, Blick S, Baasner A, Heller R. Wirth B, et al. Among authors: blick s. Hum Genet. 2006 May;119(4):422-8. doi: 10.1007/s00439-006-0156-7. Epub 2006 Mar 1. Hum Genet. 2006. PMID: 16508748

3

Correction: A response to recent penile enlargement industry media report.

Valenzuela R, Levine L, Tajkarimi K, Gheiler E, Blick S, Karpman E, Kansas B, Wilson SK. Valenzuela R, et al. Among authors: blick s. Int J Impot Res. 2024 May;36(3):301. doi: 10.1038/s41443-024-00877-8. Int J Impot Res. 2024. PMID: 38565671 No abstract available.

4

A response to recent penile enlargement industry media report.

Valenzuela R, Levine L, Tajkarimi K, Gheiler E, Blick S, Karpman E, Kansas B, Wilson SK. Valenzuela R, et al. Among authors: blick s. Int J Impot Res. 2023 Sep;35(6):509-511. doi: 10.1038/s41443-023-00745-x. Epub 2023 Jul 26. Int J Impot Res. 2023. PMID: 37495796 Review. No abstract available.

5

Platelet factor 4 increases bone marrow B cell development and differentiation.

Field DJ, Aggrey-Amable AA, Blick SK, Ture SK, Johanson A, Cameron SJ, Roy S, Morrell CN. Field DJ, et al. Among authors: blick sk. Immunol Res. 2017 Oct;65(5):1089-1094. doi: 10.1007/s12026-017-8951-x. Immunol Res. 2017. PMID: 28914425 Free PMC article.

6

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.

Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group. Nitti VW, et al. J Urol. 2017 Feb;197(2S):S216-S223. doi: 10.1016/j.juro.2016.10.109. Epub 2016 Dec 22. J Urol. 2017. PMID: 28012773 Clinical Trial.

7

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study.

Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C; 191622-096 Investigators. Nitti VW, et al. J Urol. 2016 Sep;196(3):791-800. doi: 10.1016/j.juro.2016.03.146. Epub 2016 Mar 30. J Urol. 2016. PMID: 27038769 Clinical Trial.

8

OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.

Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group. Nitti VW, et al. J Urol. 2013 Jun;189(6):2186-93. doi: 10.1016/j.juro.2012.12.022. Epub 2012 Dec 14. J Urol. 2013. PMID: 23246476 Clinical Trial.

9

Telavancin.

Lyseng-Williamson KA, Blick SK. Lyseng-Williamson KA, et al. Among authors: blick sk. Drugs. 2009;69(18):2607-20. doi: 10.2165/10481380-000000000-00000. Drugs. 2009. PMID: 19943710

10

Spotlight on teriparatide in osteoporosis.

Blick SK, Dhillon S, Keam SJ. Blick SK, et al. BioDrugs. 2009;23(3):197-9. doi: 10.2165/00063030-200923030-00006. BioDrugs. 2009. PMID: 19627171 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page